title: [Evaluation of co-morbidities and co-morbidity evaluation scores].
abstract: A treatment is beneficial when it leads to an increase in the duration and/or quality of life. The evaluation of all patients before treatment should allow an estimate of morbidity, mortality of treatment on the patient and tailor the treatment the patient's physiological conditions. The scales of assessment of competitive morbidity and measurement of the level of activity provide useful prognostic information to help the practitioner in its therapeutic decision.
authors.affiliation: Service d'Urologie, Hôpital Foch, 40, rue Worth, 92150 Suresnes, France. y.neuzillet@hopital-foch.org
authors.forename: Y
authors.initials: Y
authors.lastname: Neuzillet
mesh_terms: D000368:Aged; D006305:Health Status Indicators; D006801:Humans; D014571:Urologic Neoplasms / Q000150:complications*